Laquinimod for treating relapsing-remitting multiple sclerosis [ID560]
Discontinued
Reference number: GID-TAG337
Following on from information provided to NICE by the company in May 2012, the appraisal of Laquinimod for treating relapsing-remitting multiple sclerosis [560] was suspended from NICE’s work programme. As no further information has been received from the company the topic has been discontinued.